This webinar will give you a better understanding of how the end of one-size-fits all medicine, and current oncology drug developments in diagnosis and biomarkers positively impact clinical trials. It will also address key oncology drug development barriers and best practices to overcome them. You’ll learn about a breakthrough strategy that is changing the way sponsors conduct their clinical trials.
François Le Barbenchon
Director of Clinical Operations
Director of Scientific Affairs
Manager Business Development